FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implant, Dermal, For Aesthetic Use
PMA: P090016
·
Supplement: S049
·
Decision Oct 26, 2022
Classifications
1
FEI Numbers
29
Registration Numbers
29
Basic Information
- Device Name
- Implant, Dermal, For Aesthetic Use
- Trade Name
- Belotero Balance (+) Lidocaine
- PMA Number
- P090016
- Supplement Number
- S049
- Device Class
- FDA Class 3
- Product Code
- LMH
- Generic Name
- Implant, dermal, for aesthetic use
- Medical Specialty
- Unknown
- Advisory Committee
- General, Plastic Surgery
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- October 26, 2022
- Date Received
- July 21, 2022
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval to increase the tolerance range for the lidocaine hydrochloride specification from 3.00 ± 5% mg/mL (2.85-3.15 mg/mL) to 3.0 ± 10% mg/mL (2.7 - 3.3 mg/mL).
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LMH | Implant, Dermal, For Aesthetic Use | FDA class 3 | Unknown |